Naloxone is an opioid overdose reversal drug that has been licenced by the U.S. Food and Drug Administration (FDA). It is an opioid antagonist, which means it attaches to opioid receptors and can counteract and prevent the effects of opioids such as heroin, morphine, and oxycodone. Intranasal spray (into the nose), intramuscular (into the muscle), subcutaneous (under the skin), and intravenous injection are all options for administering the medicine. Naloxone is widely available over the counter at pharmacies in the U.S. as it is not prescribed medicine. Naloxone can also be obtained for free from community-based distribution initiatives, local public health groups, or local health departments.
Key players in the market are focused on adopting strategies such as partnerships, acquisitions, and programs to expand their product portfolio which is expected to drive the market growth. For instance, on October 22, 2021, Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, announced the donation of 50,000 vials of Naloxone HCl Injection, USP – a treatment for reversing opioid overdoses to members of the Opioid Safety and Naloxone Network (OSNN) Buyers Club to help ease an acute shortage of the medicine currently facing non-profit harm-reduction programs which includes treatments for HIV, hepatitis C virus (HCV), HBV counseling and testing, and naloxone for overdose in the U.S. the Opioid Safety and Naloxone Network (OSNN) is a network of over 100 harm-reduction programs in the U.S that distribute naloxone to drug users and their families. Some of its member programs have been participating in community naloxone distribution for over 20 years. Hikma's donation will come from its state-of-the-art sterile injectable manufacturing facility in Cherry Hill, New Jersey, and will be made in collaboration with Hikma Community Health, a new division of Hikma dedicated to providing a variety of treatment options for substance use disorder and opioid overdose in the U.S.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
*Browse 39 market data tables and 42 figures on "U.S. Naloxone Market” - forecast to 2030